Melinta Therapeutics’ New Drug Application for Baxdela Accepted for Filing by US FDA
January 05, 2017 08:00 ET
|
Melinta Therapeutics
NEW HAVEN, Conn., Jan. 05, 2017 (GLOBE NEWSWIRE) -- Melinta Therapeutics, a privately held company developing novel antibiotics to treat serious bacterial infections, announced today the U.S....